Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > i could be wrong but....

<< Previous

Bullboard Posts

Next >>

Comment by cbriton Oct 20, 2009 2:23am

386 Views

Post# 16402670

RE: i could be wrong but....

You are right..... but not with this kind of volume. This is the most HLO has ever traded by far so I doubt a PP would do this. I'd say results have leaked out.

cb

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario